ALERT LINE
Could this common painkiller become a future cancer-killer? | KurzweilAI

Could this common painkiller become a future cancer-killer? | KurzweilAI

Diclofenac, a common painkiller, has significant anti-cancer properties, researchers from the Repurposing Drugs in Oncology (ReDO) project have found.

ReDO, an international collaboration between the Belgium-based Anticancer Fund and the U.S.- based GlobalCures, has published their investigation into diclofenac in the open-access journal ecancermedicalscience.

Diclofenac is a well-known non-steroidal anti-inflammatory drug…

Source: Could this common painkiller become a future cancer-killer? | KurzweilAI